361576-47-8

Basic information

• Product Name: Benzenepropanoic acid, 4-hydroxy-a-(1-oxopropyl)-, methyl ester
• CAS NO: 361576-47-8
• Molecular Formula: C13H16O4
• Molecular Weight: 236.268
• Mol File: 361576-47-8.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: Benzenepropanoic acid, 4-hydroxy-a-(1-oxopropyl)-, methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Benzenepropanoic acid, 4-hydroxy-a-(1-oxopropyl)-, methyl ester(361576-47-8)
• EPA Substance Registry System: Benzenepropanoic acid, 4-hydroxy-a-(1-oxopropyl)-, methyl ester(361576-47-8)

Safety Data

• Hazardous Substances Data: 361576-47-8(Hazardous Substances Data)

Upstream product

• 30414-53-0 methyl propanoyl acetate 
• 123-08-0 4-hydroxy-benzaldehyde 
• 540-38-5 p-Iodophenol 
• 133181-02-9 3-hydroxy-2-methylene-pentanoic acid methyl ester 
• 851181-18-5 2-(4-hydroxy-benzyliden)-3-oxo-pentanoic acid methyl ester 

Downstream Products

• 932025-00-8 3-ethoxyimino-2-{4-[2-(5-methyl-2-phenyl-oxazol-4-yl)-ethoxy]-benzyl}-pentanoic acid methyl ester 
• 932024-99-2 3-methoxyimino-2-{4-[2-(5-methyl-2-phenyl-oxazol-4-yl)-ethoxy]-benzyl}-pentanoic acid methyl ester 
• 851181-40-3 3-ethyloxyimino-2-(4-hydroxy-benzyl)-pentanoic acid methyl ester 
• 851181-19-6 2-(4-hydroxy-benzyl)-3-methoxyimino-pentanoic acid methyl ester 

Relevant articles and documents

Morita-Baylis-Hillman adducts as building blocks of heterocycles: a simple approach to 4-substituted pyrazolones, and mechanism investigation via ESI-MS(/MS)

Abstract We describe herein an efficient approach for the preparation of 4-substituted 2,3-dihydro-1H-pyrazol-3-ones starting from Morita-Baylis-Hillman adducts. These heterocycles were obtained in two or three steps as single isomers with moderate to goo

NOVEL COMPOUNDS AS AGONIST FOR PPAR GAMMA AND PPAR ALPHA, METHOD FOR PREPARATION OF THE SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME

The present invention relates to novel compounds accelerating the activity of Peroxisome proliferator-activated receptor gamma (PPARγ) and alpha (PPARα), processes of preparing the same, and pharmaceutical compositions containing the same as an active agent.